Axplora has initiated global investments exceeding €100 million in 2025 [...]

Confo Therapeutics has been awarded a EUR 1 million grant [...]

Complement Therapeutics GmbH (CTx) has received clearance from the FDA [...]

Owlstone Medical has received an award of up to $49.1 [...]

Alto Neuroscience has received FDA Fast Track designation for its [...]

Protagonist Therapeutics has reported new clinical and preclinical data at [...]

Thermo Fisher Scientific’s PPD clinical research business has entered into [...]

Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]

Levicept Ltd will present new findings from its Phase 2 [...]

SeaBeLife, a biotechnology company developing novel drug candidates to block [...]